Abstract
Metabolism, whose reprogramming is an established cancer hallmark, promotes growth and proliferation in cancer cells. Genome-wide metabolic models are becoming increasingly capable of describing cancer growth. Multiscale models may allow the capture of other relevant features of cancer cells and their relationship with the tumor microenvironment. The merging of multiscale metabolic modeling and artificial intelligence can lead to a paradigm shift in oncology, possibly leading to patient-specific personalized digital twins.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
